Related Experiment Video

Updated: Aug 15, 2026

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
04:56

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells

Published on: October 23, 2018

Glucocorticoids in prevention of respiratory distress syndrome

P L Ballard, R A Ballard

    Hospital Practice
    |September 1, 1980
    PubMed

    Insights

    Administering low doses of betamethasone within 48 hours before delivery effectively prevents neonatal respiratory distress syndrome (RDS) in premature infants. This steroid treatment is most beneficial for babies between 26 and 34 weeks gestation.

    Area of Science:

    • Obstetrics and Gynecology
    • Neonatology
    • Pharmacology

    Background:

    • Neonatal Respiratory Distress Syndrome (RDS) is a significant cause of morbidity and mortality in premature infants.
    • Antenatal corticosteroid therapy is a cornerstone in managing preterm birth risks.

    Purpose of the Study:

    • To outline guidelines for the effective use of betamethasone in preventing neonatal RDS.
    • To detail the optimal timing and dosage of antenatal betamethasone administration.
    • To review the potential hazards and mechanisms of action of glucocorticoids in preventing RDS.

    Main Methods:

    • Review of clinical guidelines and evidence for antenatal betamethasone use.
    • Analysis of optimal gestational age (26-34 weeks) and timing (48 hours pre-delivery) for administration.
    • Discussion of glucocorticoid mechanisms in fetal lung maturation.

    Main Results:

    • Low-dose betamethasone is effective in preventing neonatal RDS.
    • Optimal efficacy is achieved when administered 48 hours prior to delivery for infants between 26 and 34 weeks gestation.
    • Guidelines for safe and effective administration are provided.

    Conclusions:

    • Antenatal betamethasone is a crucial intervention for reducing RDS in preterm neonates.
    • Adherence to recommended timing and dosage maximizes therapeutic benefits.
    • Understanding the risks and mechanisms enhances clinical application.

    More Related Videos

    Intratracheal Instillation of Stem Cells in Term Neonatal Rats04:27

    Intratracheal Instillation of Stem Cells in Term Neonatal Rats

    Published on: May 4, 2020

    Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

    Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

    Published on: September 24, 2020

    Related Concept Videos

    Drugs Used in Lower Respiratory Disorders: Overview01:17

    Drugs Used in Lower Respiratory Disorders: Overview

    Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
    Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
    Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

    Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

    Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
    Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
    Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

    Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

    Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
    ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
    COPD: Management Using Bronchodilators and Corticosteroids01:26

    COPD: Management Using Bronchodilators and Corticosteroids

    Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

    Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
    Acute Respiratory Failure-V01:29

    Acute Respiratory Failure-V

    The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
    Ensure that patients are monitored continuously for their response to therapy, including changes in...